State of Wisconsin Investment Board
KRYS icon

State of Wisconsin Investment Board’s Krystal Biotech KRYS Stock Holding History

State of Wisconsin Investment Board’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.34M Buy
20,691
+6,225
+43% +$1.66M 0.01% 955
2025
Q4 		$3.57M Sell
14,466
-14,874
-51% -$3.13M 0.01% 1139
2025
Q3 		$5.18M Sell
29,340
-6,749
-19% -$1.01M 0.01% 938
2025
Q2 		$4.96M Buy
36,089
+11,906
+49% +$1.75M 0.01% 934
2025
Q1 		$4.36M Sell
24,183
-319
-1% -$53.7K 0.01% 983
2024
Q4 		$3.84M Buy
24,502
+1,434
+6% +$254K 0.01% 1053
2024
Q3 		$4.2M Sell
23,068
-2,242
-9% -$432K 0.01% 1019
2024
Q2 		$4.65M Buy
25,310
+9,095
+56% +$1.53M 0.01% 966
2024
Q1 		$2.89M Buy
16,215
+1,319
+9% +$183K 0.01% 1139
2023
Q4 		$1.85M Sell
14,896
-5,731
-28% -$636K 0.01% 1250
2023
Q3 		$2.39M Buy
20,627
+3,900
+23% +$476K 0.01% 1198
2023
Q2 		$1.96M Buy
16,727
+156
+0.9% +$15.9K 0.01% 1297
2023
Q1 		$1.33M Sell
16,571
-968
-6% -$76K ﹤0.01% 1403
2022
Q4 		$1.39M Sell
17,539
-208
-1% -$15.4K ﹤0.01% 1407
2022
Q3 		$1.24M Sell
17,747
-1,113
-6% -$80.4K ﹤0.01% 1466
2022
Q2 		$1.24M Sell
18,860
-4,540
-19% -$282K ﹤0.01% 1513
2022
Q1 		$1.56M Sell
23,400
-3,800
-14% -$237K ﹤0.01% 1559
2021
Q4 		$1.9M Buy
27,200
+3,800
+16% +$221K ﹤0.01% 1291
2021
Q3 		$1.22M Buy
23,400
+4,500
+24% +$266K ﹤0.01% 1392
2021
Q2 		$1.28M Hold
18,900
– – ﹤0.01% 1383
2021
Q1 		$1.46M Hold
18,900
– – ﹤0.01% 1287
2020
Q4 		$1.13M Sell
18,900
-200
-1% -$9.99K ﹤0.01% 1295
2020
Q3 		$822K Buy
19,100
+2,900
+18% +$126K ﹤0.01% 1338
2020
Q2 		$671K Hold
16,200
– – ﹤0.01% 1340
2020
Q1 		$700K Buy
16,200
+3,100
+24% +$162K ﹤0.01% 1266
2019
Q4 		$725K Hold
13,100
– – ﹤0.01% 1328
2019
Q3 		$455K Buy
+13,100
New +$586K ﹤0.01% 1361

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's KRYS Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Krystal Biotech (KRYS) stake by 43% in Q1 2026, buying an estimated $1.66M and bringing the position to 20,691 shares worth $5.34M. The position accounts for 0.01% of the portfolio, ranked #955.

State of Wisconsin Investment Board first reported a position in KRYS in Q3 2019 and has held it in 27 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • State of Wisconsin Investment Board held 20,691 shares of Krystal Biotech worth $5.34M as of Q1 2026.
  • State of Wisconsin Investment Board bought 6,225 Krystal Biotech shares in Q1 2026, an estimated $1.66M.
  • Krystal Biotech made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #955 holding.
  • State of Wisconsin Investment Board first reported a position in Krystal Biotech in Q3 2019 and has held it in 27 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.